As clinical trials grow more complex and globally distributed, financial management is becoming a strategic priority — not just an operational function.
Traditional outsourcing models can limit visibility and control, while fully internalizing processes introduces new challenges around scale, expertise, and systems integration.
This article explores how organizations are rethinking their approach to clinical trial financial management, including:
The drivers behind bringing financial processes in-house
The balance between technology enablement and human expertise
Key considerations for improving transparency, compliance, and efficiency
Take a closer look at how leading teams are evolving their financial operations to support more agile, data-driven trials.